In patients with acute EBV infection, EBVCA-IgM titers peak at 3–4 weeks after infection, whereas EBVCA-IgG titers peak at 1–2 months after infection, then decrease slightly and remain in the body for the rest of a patient's life. The gene discussed is CD40LG; the disease is Epstein-Barr virus infection.